Search: „100% Pass Quiz IIA - Pass-Sure IIA-CIA-Part3 - Business Knowledge for Internal Auditing Valid Braindumps Free 📊 Simply search for 【 IIA-CIA-Part3 】 for free download on ▷ www.pdfvce.com ◁ 🤨IIA-CIA-Part3 Pdf Dumps“

froodies (www.froodies.de), which claims to be Germany's first online supermarket for fresh groceries, has received new investment capital in the course of a second round of financing. In addition to the initial investor Sirius Venture, High-Tech Gründerfonds and several business angels have also joined as investors. The start-up company from Düsseldorf is investing the funds in strategic growth and nationwide expansion. “We believe that froodies, with its decentralized delivery system and

OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation (AF), today announced that it has raised EUR 6.2 million in a Series A round. Participating in the round were Vesalius Biocapital II S.A. SICAR, acting as lead; a SMS Group Company; VC Fonds Technologie Berlin; High-Tech Gruenderfonds (HTGF); and KfW Group. As part of the financing round, the company has

Seven-digit cash injection for Hamburg startup Bertelsmann Digital Media Investments (BDMI), the venture capital fund of Bertelsmann SE & Co. KGaA, Holtzbrinck Ventures and the incubator Project A have joined the High-Tech Gründerfonds in investing a seven-digit sum into Semasio GmbH. The Hamburg startup will use the funds to fuel its continued geographical expansion, and accelerate its product and technology development. Semasio develops technology for tailoring online display advert

Innovative technology enables ultra-light and dynamic actuators for industrial applications in robotics, aerospace and automotive industry The Munich-based tech start-up MetisMotion has received more than one million Euro in fresh capital in its first financing round. The investors are High-Tech Gründerfonds (HTGF), BORN2GROW Seedfonds - a subsidiary of ZFHN Zukunftsfonds Heilbronn - and SIEMENS Technology Accelerator (STA). MetisMotion's core technology includes highly dynamic and lightweig

The High-Tech Gründerfonds and the MBG Schleswig-Holstein renew their investment in eyefactive GmbH. A six digit sum is provided to promote the international growth of the first app platform for professional Touchscreens. In addition to their previous portfolio of scalable multitouch technology for interactive tables and walls eyefactive GmbH announced the world´s first app platform for large-scale touchscreens in November 2013. The apps enable users to simultaneously operate interactive co

coramaze technologies GmbH, a German company founded and based in Essen as a spin-off from the Western German Heart Center, is developing an innovative medical device for the minimally invasive treatment of one of the most common structural heart valve diseases, mitral regurgitation. The mitramaze® valve repair system technology has been developed through a technological research project funded by the EXIST research transfer of the German Federal Ministry of Economics and Technology. The compan

HepaRegeniX GmbH, a new Biotech company developing innovative treatments for liver diseases, announced today the completion of a €9 million Series A financing. The round was led by Boehringer Ingelheim Venture Fund GmbH (BIVF) and Novo Seeds, and complemented by the High-Tech Gruenderfonds and coparion. HepaRegeniX develops a new and unique therapeutic concept for the treatment of liver diseases, discovered by Prof. Lars Zender and his research group at the University Hospital Tubingen, Ger

AudioCure, a pharmaceutical R&D company headquartered in Germany, announces today that it has secured an A-round of about EUR 9 million from MED-EL, HTGF and private investors. MED-EL receives exclusive licensing rights and shares while existing investors increase their shares. AudioCure will use the funding to get its front-runner small molecule AC102 into Phase I clinical trials in auditory disorders including acute hearing loss and acute tinnitus. To date, there are no approved therapeuti

Following the sale of their portfolio company CorImmun GmbH to Janssen-Cilag for an undisclosed upfront payment and a contingent future clinical milestone payment, Corimmun’s investors led by MIG have realized an important return on investment. CorImmun’s lead compound, COR-1, is a small cyclic peptide currently in early clinical development for the treatment of heart failure. COR-1 has been shown in preclinical studies to improve heart function by decreasing autoimmune, beta 1 receptor-s

AYOXXA Biosystems GmbH, an international biotechnology company, completed a € 9,0m Series B financing round by the end of June 2014. All of the company’s existing investors (High-Tech Gründerfonds, KFW, NRW.BANK, Wellington Partners Venture Capital and private investors) took part, along with new investors b-to-v Partners AG, Creathor Venture and HR Ventures. In addition several private investors from the US and Europe, including AYOXXA employees and two of Qiagen’s founders, joined this

With the support of its latest investor, High-Tech Gründerfonds (HTGF), qLearning has launched an online platform that enables students and teachers of any discipline to create and share their own study materials. The platform is designed to complement qLearning’s popular mobile app, which already boasts a user base of more than 80,000 students. It also ensures the company keeps up with the ever-evolving student demand for practical learning tools. The investment by HTGF completes this year�

High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and allows the early detection of possible side effects during the drug development process. Thereby, the need for animal testing will be reduced while the drug becomes safer and the process more cost-efficient. S

FreiGeist award to be issued for the first time - On 6 May 2010, High-Tech Gründerfonds, Thierhoff Consulting and Censet GmbH are hosting the first FreiGeist Conference at Clublounge Nord of Cologne’s RheinEnergieStadion football stadium. Founders, web entrepreneurs, business angels, students, consultants and all who are interested in start-ups, the internet and new media are invited to the Dome capital of Cologne. The focus of the one-day conference is a framework programme which will fee